San Diego, CA, United States of America

Chung-Mao Pan

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Chung-Mao Pan in Cancer Treatment

Introduction

Chung-Mao Pan is a notable inventor based in San Diego, CA, who has made significant contributions to the field of pharmaceuticals. He holds two patents that focus on cyclic peptide analogs and their applications in cancer treatment. His work is pivotal in advancing therapeutic options for patients battling cancer.

Latest Patents

Chung-Mao Pan's latest patents include innovative cyclic peptide analogs and conjugates. These patents provide detailed descriptions of cyclic peptide analogs, conjugates comprising such compounds, and pharmaceutical compositions that utilize these compounds. Furthermore, they outline methods of treating cancer with these compounds and conjugates, showcasing his commitment to improving cancer therapies.

Career Highlights

Throughout his career, Chung-Mao Pan has demonstrated a strong dedication to research and development in the pharmaceutical industry. His work at Sirenas LLC has positioned him as a key player in the development of novel therapeutic agents. His contributions have not only advanced scientific knowledge but also have the potential to impact patient care positively.

Collaborations

Chung-Mao Pan collaborates with talented individuals such as Ippei Usui and Bryan Junn Lee. These partnerships enhance the innovative capacity of his projects and contribute to the successful development of new treatments.

Conclusion

Chung-Mao Pan's work in developing cyclic peptide analogs represents a significant advancement in cancer treatment. His patents and collaborations reflect his commitment to innovation in the pharmaceutical field. The impact of his inventions may lead to improved outcomes for cancer patients in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…